Key result
Global IHD cases more than doubled to ~597 million since 1990 despite stable age-standardized rates.
Observational
Effect estimate: EAPC 0.01 (95% CI -0.06-0.08)
Absolute Event Rate: 743.5% vs 775.9%
Despite declines in age-standardized rates of ischemic heart disease, the absolute global burden has doubled from 1990 to 2021 due to population growth and aging, highlighting the need for targeted preventive strategies.
Rising absolute IHD burden may reflect demographic pressures; leaves open optimal prevention targets in GBD observational data.
Ischemic heart disease (IHD) remains a leading global health burden influenced by demographic transitions, socioeconomic disparities, and modifiable risk factors. Comprehensive analyses of global patterns are crucial to inform public health interventions. Using data from the Global Burden of Disease study 2021, we assessed global, regional, and national trends in IHD burden (1990-2021). Age-standardized rates of incidence, prevalence, mortality, and disability-adjusted life-years were evaluated. Trends were analyzed using estimated annual percentage change, age-period-cohort models, Bayesian forecasts, risk-factor attribution, decomposition analyses, health inequality, and frontier efficiency analyses. From 1990 to 2021, global IHD prevalence nearly doubled despite stable age-standardized rates, driven by population aging and growth. Eastern Europe exhibited consistently high disease burdens compared to sub-Saharan Africa. Significant gender disparities persisted, with higher burdens among males. High blood pressure, low-density lipoprotein cholesterol, and dietary risks dominated globally. Although age-standardized incidence and mortality declined, especially in high-sociodemographic index countries, absolute numbers increased due to demographic momentum. Forecasts suggest continued increases in absolute cases and deaths through 2035 despite declining standardized rates.Despite reductions in age-standardized IHD burden, substantial disparities persist. Future strategies should address demographic drivers, expand preventive efforts in lower-sociodemographic index regions, and enhance health system efficiency.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) conducted an observational in Ischemic heart disease. Time (1990 to 2021) vs. 1990 baseline was evaluated on Age-standardized prevalence rate of IHD per 100,000 population (EAPC 0.01, 95% CI -0.06-0.08). From 1990 to 2021, the global number of prevalent ischemic heart disease cases increased from 282.9 million to 597.0 million, despite a stable age-standardized prevalence rate (EAPC 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: